Section Arrow
Quote
ALUR.NYSE
- Allurion Technologies
(Financial Status)
Quotes are at least 15-min delayed:2025/12/09 01:57 EST
Regular Hours
Last
 1.68
-0.02 (-1.18%)
Day High 
1.7 
Prev. Close
1.7 
1-M High
1.85 
Volume 
30.76K 
Bid
1.64
Ask
1.7
Day Low
1.64 
Open
1.68 
1-M Low
1.02 
Market Cap 
20.84M 
Currency 美元 
P/E -- 
%Yield -- 
10-SMA 1.49 
20-SMA 1.48 
50-SMA 1.77 
52-W High 16.81 
52-W Low 1.02 
Exchange NYSE 
Valuation Estimation
EPS (Current/Estimated)
-16.20/2.06
Enterprise Value
57.89M
Balance Sheet
Book Value Per Share
-6.77
Cash Flow
Cash Flow Yield
--
Income Statement
Total Revenue
32.11M
Operating Revenue Per Share
5.08
Industry Comparison
More
Code Name   Last Change Change (%) P/E P/E Range
PFSAProfusa Inc0.1984+0.0214+12.09%-- 
BSXBoston Scientific Corp93.84-3.68-3.77%52.15PE
BFLYButterfly Network3.14+0.08+2.61%-- 
ABTAbbott Laboratories122.09-2.99-2.39%15.71PE
WOKWORK Medical Technology Group LTD.4.85-0.38-7.27%-- 
Industry overview quotes are at least 15 minutes delayed
Business Description
Allurion Technologies Inc is a medical device company that focuses on creating a weight loss platform to treat overweight patients. Its platform, the Allurion Program, features the world's first and only swallowable, procedure-less intragastric balloon for weight loss and offers access to AI-powered remote patient monitoring tools, a proprietary behavior change program, secure messaging, and video telehealth that are delivered by the Allurion VCS. Its proprietary intragastric balloon, the Allurion Balloon, is in the form of a swallowed capsule that is administered to patients under the guidance of a healthcare provider without surgery, endoscopy, or anesthesia.
Information provided by: etnet
Terms and Conditions
Bank of China (Hong Kong) Limited
Disclaimer:
This information is provided by ET Net Limited ("ET Net") and/or its third party information providers (the "Sources") and is strictly for reference only. It is not intended to provide any financial or professional advice and any person should not rely upon the same as such. You should obtain relevant and specific professional advice before making any investment decision. Before making an investment decision, you should consider, with the assistance of your professional securities adviser, whether the information is appropriate in light of your particular investment needs, objectives and financial circumstances. ET Net and the Sources endeavor to ensure the accuracy and reliability of the information provided. Notwithstanding the aforesaid, ET Net, the Sources and Bank of China (Hong Kong) Limited do not guarantee or make any representation, warranty or undertaking as to the accuracy, reliability, completeness or timeliness of this information, and accept no responsibility or liability whatsoever (whether in tort or contract or otherwise) for any loss or damage howsoever arising from or in reliance upon the whole or any part of such information.